Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
5,900
Employees5,900
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
5,900
Employees5,900

MEDP Key Statistics

Market cap
12.16B
Market cap12.16B
Price-Earnings ratio
28.02
Price-Earnings ratio28.02
Dividend yield
Dividend yield
Average volume
601.89K
Average volume601.89K
High today
$442.41
High today$442.41
Low today
$420.00
Low today$420.00
Open price
$421.45
Open price$421.45
Volume
654.33K
Volume654.33K
52 Week high
$628.92
52 Week high$628.92
52 Week low
$250.05
52 Week low$250.05

Stock Snapshot

The current Medpace(MEDP) stock price is $428.03, with a market capitalization of 12.16B. The stock trades at a price-to-earnings (P/E) ratio of 28.02.

During the trading session on 2026-02-15, Medpace(MEDP) shares reached a daily high of $442.41 and a low of $420.00. At a current price of $428.03, the stock is +1.9% higher than the low and still -3.3% under the high.

Trading volume for Medpace(MEDP) stock has reached 654.33K, versus its average volume of 601.89K.

The stock's 52-week range extends from a low of $250.05 to a high of $628.92.

The stock's 52-week range extends from a low of $250.05 to a high of $628.92.

MEDP News

Simply Wall St 15h
Medpace Holdings Is Down 21.0% After Mixed 2026 Guidance and Elevated Trial Cancellations

In February 2026, Medpace Holdings reported past fourth-quarter 2025 results showing revenue of US$708.45 million and GAAP diluted EPS of US$4.67, alongside ful...

Medpace Holdings Is Down 21.0% After Mixed 2026 Guidance and Elevated Trial Cancellations
TipRanks 2d
Medpace upgraded to Buy from Hold at Jefferies

Jefferies analyst David Windley upgraded Medpace (MEDP) to Buy from Hold with an unchanged price target of $560. The firm says biotech funding has “inflected me...

Simply Wall St 3d
Assessing Medpace Holdings Valuation After Recent Share Price Pullback

Advertisement Medpace Holdings stock overview Medpace Holdings (MEDP) has recently drawn investor attention after a period of weaker share performance, with t...

Assessing Medpace Holdings Valuation After Recent Share Price Pullback

Analyst ratings

47%

of 15 ratings
Buy
20%
Hold
46.7%
Sell
33.3%

More MEDP News

TipRanks 4d
Medpace Holdings’ Earnings Call Signals Growth Amid Volatility

Medpace Holdings Inc ((MEDP)) has held its Q4 earnings call. Read on for the main highlights of the call. Valentine's Day Sale - 70% Off Unlock hedge fund-level...

Nasdaq 5d
Medpace Q4 2025 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Medpace Q4 2025 Earnings Call Transcript
TipRanks 5d
CRO peers lower after Medpace earnings, comments on cancellations

Shares of Contract Research Organizations including Icon plc (ICLR), Fortrea (FTRE) and Charles River Labs (CRL) are trading lower after peer Medpace (MEDP) rep...

Nasdaq 5d
Medpace Holdings, Inc. Q4 Income Advances, Beats Estimates

(RTTNews) - Medpace Holdings, Inc. (MEDP) released a profit for its fourth quarter that Increased, from last year and beat the Street estimates. The company's...

Medpace Holdings, Inc. Q4 Income Advances, Beats Estimates

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.